MedTrace Logo

Comparison of Verofilcon A Daily Disposable Lenses to Somofilcon A Daily Disposable Lenses

NCT04305912 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 51

Last updated 2022-02-14

Study results available
· View outcomes & findings →

Summary

The objective of the study is to evaluate and compare the performance of verofilcon A to somofilcon A when worn on a daily disposable modality over a period of approximately one week each.

Conditions

  • Myopia

Interventions

DEVICE

somofilcon A

Subjects will be randomized to wear somofilcon A daily disposable lenses.

DEVICE

verofilcon A

Subjects will be randomized to wear verofilcon A daily disposable lenses.

Sponsors & Collaborators

  • CooperVision, Inc.

    lead INDUSTRY

Principal Investigators

  • Lyndon Jones, PhD FCOptom · University of Waterloo

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
17 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-02-19
Primary Completion
2021-08-28
Completion
2021-08-30
FDA Device
Yes

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04305912 on ClinicalTrials.gov